Study is one of five submitted to U.S. FDA by Janssen as part of its new drug application for esketamine nasal spray for treatment-resistant depression
PR Newswire
TITUSVILLE, N.J., Sept. 21, 2018
PR Newswire
TITUSVILLE, N.J., Sept. 21, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey